title: KRAS gene mutations are more common in colorectal villous adenomas and in situ carcinomas than in carcinomas.
abstract: We have evaluated the frequency of KRAS gene mutations during the critical transition from villous adenoma to colorectal carcinoma to assess whether the adenomas contain a KRAS mutation more frequently than carcinomas. We analyzed sporadic villous and tubulovillous adenomas, in situ carcinomas, and primary colorectal carcinomas from multiple patients. The cancers were further evaluated for mucinous status and microsatellite instability. Standard PCR molecular techniques were used for KRAS and microsatellite analyses. A KRAS mutation was found in 61.9% of 134 adenomas, 67.8% of 84 in situ carcinomas, and just 31.6% of 171 carcinomas. Our study clearly demonstrates that tubulovillous and villous adenomas, as well as both the benign and malignant parts of in situ carcinomas, are statistically more likely to contain a somatic KRAS gene mutation than colorectal carcinomas. This difference is confined to the non-mucinous and the microsatellite stable tumors. Our data support the possibility that non-mucinous and microsatellite stable carcinomas with wild-type KRAS gene may have had a mutation in the KRAS gene during their earlier stages, with the mutation lost during further growth.
authors.affiliation: Department of Medicine, Saint Barnabas Medical Center Livingston NJ 07039, USA.
authors.forename: Peter
authors.initials: P
authors.lastname: Zauber
authors.forename: Stephen
authors.initials: S
authors.lastname: Marotta
authors.forename: Marlene
authors.initials: M
authors.lastname: Sabbath-Solitare
keywords: KRAS gene; colorectal adenomas; colorectal carcinoma; microsatellite instability; tubulovillous adenoma; villous adenoma
references.citation: Mod Pathol. 2006 Jan;19(1):59-68
references.pmid: 16118624
references.citation: Br J Cancer. 1997;75(3):341-7
references.pmid: 9020477
references.citation: N Engl J Med. 2006 Nov 2;355(18):1863-72
references.pmid: 17079760
references.citation: Gastroenterology. 2005 Jun;128(7):1907-18
references.pmid: 15940626
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1443-50
references.pmid: 16896030
references.citation: Gastroenterology. 2007 Jul;133(1):48-56
references.pmid: 17631130
references.citation: Int J Colorectal Dis. 1999 Nov;14(4-5):194-200
references.pmid: 10647627
references.citation: Br J Cancer. 2011 Feb 1;104(3):464-8
references.pmid: 21224857
references.citation: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50
references.pmid: 20876136
references.citation: Semin Cancer Biol. 2002 Aug;12(4):261-6
references.pmid: 12147207
references.citation: N Engl J Med. 2008 Oct 23;359(17):1757-65
references.pmid: 18946061
references.citation: Cancer. 2005 Aug 15;104(4):719-29
references.pmid: 15959913
references.citation: J Clin Pathol. 1999 Jun;52(6):455-60
references.pmid: 10562815
references.citation: Nature. 2009 Apr 9;458(7239):719-24
references.pmid: 19360079
references.citation: J Pathol. 2001 Mar;193(3):303-9
references.pmid: 11241408
references.citation: J Clin Oncol. 2011 May 20;29(15):2011-9
references.pmid: 21502544
references.citation: J Natl Cancer Inst. 1998 May 6;90(9):675-84
references.pmid: 9586664
references.citation: N Engl J Med. 1988 Sep 1;319(9):525-32
references.pmid: 2841597
references.citation: Diagn Mol Pathol. 2005 Dec;14(4):213-23
references.pmid: 16319691
references.citation: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18241-2
references.pmid: 20935251
references.citation: Carcinogenesis. 2005 May;26(5):916-22
references.pmid: 15731168
references.citation: Cancer. 2006 Mar 1;106(5):1036-40
references.pmid: 16456810
references.citation: Clin Cancer Res. 2009 Dec 1;15(23):7322-9
references.pmid: 19934290